Shares of Xenoport, Inc. (Nasdaq: XNPT) were slammed 66% yesterday after receiving an FDA Complete Response letter regarding the Horizant ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE